WILSON JAMES N 4

What Happened
James N. Wilson, a director of Corcept Therapeutics (CORT), reported a gift (transaction code G) of 4,000 common shares on 2026-03-20. The Form 4 shows the disposition price as $0.00, so no cash proceeds were reported for this transfer. This was a gift (not a purchase or open-market sale) and therefore does not directly signal a buy or sell decision.

Key Details

• Transaction date: 2026-03-20 — Gift of 4,000 shares (Disposition).
• Reported price/proceeds: $0.00 per share; total reported proceeds $0.
• Filing date: 2026-03-24 — filed within the required reporting window (timely).
• Shares owned after transaction: Not specified on the filing; the reporting person disclaims beneficial ownership of shares held by related trust/family entities (see footnote).
• Notable footnote: Reporting person has voting power over shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of those shares except to the extent of his pecuniary interest (Footnote F1).
• Remarks: A power of attorney under which the form was signed is on file with the SEC.

Context
Gifts are transfers of ownership and are not equivalent to market purchases or sales for cash; they generally do not by themselves indicate the insider’s sentiment about the company’s prospects. For retail investors, this transaction should be viewed as an ownership transfer (e.g., estate planning, family transfer, or charitable gift) rather than a trading signal.